Pain Management Devices Market by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others); By Region (U.S., Canada, Mexico, Rest of North America, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific, Brazil, Argentina Rest of Latin America, GCC countries, Southern Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
The global pain management devices market was valued at US$ 5020.62 million in 2018 and is expected to reach US$ 9095.12 million by 2027, growing at an estimated CAGR of 6.8% over the forecast period. Pain management is a field of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain lasts for a longer period of time, which adds to the need for medication. Pain management systems are medical devices used to treat different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain and others. Stimulators for the spinal cord, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and ablation devices are different types of pain management devices available on the market. Today, technology provides many drug-free alternatives to painkillers. Equipment’s like Quell, Pain Pode, Lumiwave, Omron Pain Relief Pro etc are compactable devices intended to ease up the chronic pain from conditions like fibromyalgia, sciatica, and osteoarthritis amongst others.
Growth in the global Pain Management Devices Market is driven by an increase in geriatric population and rising diabetes patients globally. WHO stated that, between 2015 and 2050, the percentage of the global population above 60 years will approximately double from 12% to 22%. And also finding further stated that by 2020, the proportion of people aged 60 years and older will surpass children younger than 5 years. This rise in country's population towards older ages started in high-income countries. Countries like japan are severely affected by it with approximately 30% of the population are already over 60 years old). Furthermore, increased demand for pain management devices among developing countries and increased acceptance of pain management devices for chronic pain management are factors contributing to market growth. In addition, untapped potential offered by developing economies is posing lucrative Pain Management Devices Market growth opportunities over the forecast period. Another major factor that is driving the market is the increasing diabetes population globally. According to the International diabetes foundation, approximately 463 million adults who are aged between 20-79 years were living with diabetes; and the statistics further claims that by 2045 it will further rise to 700 million. And approximately 374 million population are living at the risk of having diabetes due to the inherent properties of diabetes.
Development of pain management medicines is restraining the overall growth of the Pain Management Devices Market. Recently FDA Approved OTC Switch of Diclofenac Gel and Olopatadine Eye Drops followed by the approval, Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops, available over-the-counter (OTC) is expected to hinder the overall market growth
Because of numerous technological advancements in this area, the global Pain Management Devices Market is expected to see strong growth. Such developments include the introduction of devices such as wearable automated transcutaneous electrical nerve stimulators based on electrodes, which provide peripheral pain management in a 60-minute period. The major challenge faced by people while treating chronic pain is the lack of connection between pain level and severity of tissue damage due to multifaceted changes happening in immune and sensory applications. Some of the instances of pain management devices are given below:
ACTIV PRO LaserStim (Multi Radiance Medical) – The device is a portable, cordless laser therapy device system that provides fast, safe and powerful treatment without raising the skin temperature. The system delivers light to deep tissue and facilitates absorption. The system avoids exposure to radiation, phototoxicity and the death of cells. The synchronous usage of ultra-bright infrared along with super pulsed laser, red & blue LEDs are for deep penetration. This is used as a chiropractic tool all over the body. The laser therapy is effective for tendons, ligaments, muscles, nerves, bones and dermal tissues.
HEAT Pain Pro TENS Device – The device is developed by Omron Healthcare and is used for muscle pain and acute joint applications. This is an over-the-counter device and combines heat with transcutaneous electrical nerve stimulation (TENS). This provides immediate relief to muscle pain and acute joint pain.
Radiofrequency Ablation Devices: The providers of such devices are namely Boston Scientific Corporation, Diros Technology, Inc., St. Jude Medical, Inc and Haylard Health, Inc. Owing to rising chronic pain conditions and increasing geriatric population, the demand for these devices have gained traction in the recent past and is anticipated to continue the same trend over the forecast period.
ActiPatch – The aforementioned device was developed by BioElectronics Corporation and is mainly used for applications such as osteoarthritis, shingles, rheumatoid arthritis, sports injuries, neuropathy and fibromyalgia amongst others. The efficacy rate varied from 59% to 71% for different pain conditions with 50% average reduction in medication use. The device is available over-the-counter for chronic pain management. It is also safe to use with pacemakers, metal implants, defibrillators amongst others.
By Product Insights
Neuromodulation & Neurostimulation devices held the largest share in the market. It is mainly due to the increasing demand for neurological disorders and lifestyle–related disorders. Neuromodulation is a process that demands implantable medical device to control and modify neural activities for therapeutic purposes. Compared to other devices, these devices are cost efficient in nature. Moreover, manufacturers are investing more amount in research and development for the development of advanced products and technologies such as implantable neurostimulation devices, hormonal, and inflammatory processes in the central nervous system. Neurostimulation devices play a significant role in treating neuropathic pain, as stimulators for the spinal cord deliver the best outcomes. In addition, these devices offer benefits such as personalized stimulus rates, based on the activities that the individual undertakes in a day. Radiofrequency ablation devices played an important role in the management of cancer pain. Such tools exert action by thermal high temperature therapy, which causes necrotic cells to coagulate by heating tissue to 100 ° C. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
By Application Insights
Neuropathic pain held the largest share in the market in application category due to the increasing prevalence in disorders of the peripheral nervous system that affects the central nervous system. Up to 7 – 8 percentage of European population is affected. The reason for the increasing prevalence is its ability to form pain from spinal cord injury, strokes and multiple sclerosis. Global prevalence of neuropathic pain is about 7%, and with severe pain along with neuropathic characteristics was 5%.
By Regional Insights
Due to favourable healthcare facilities, North America dominated the global Pain Management Devices Market in 2018 in terms of revenue share, which enabled access to advanced pain management tools. Furthermore, government initiatives such as Precision Medicine and the Affordable Care Act, combined with well-planned reimbursement strategies, have contributed to North America's market growth. In addition, growing awareness among people and high purchasing parity has led to increased demand for these apps. During the forecast period Asia Pacific is projected to be the fastest-growing regional market due to increased government support to improve healthcare infrastructure. Economic developments in countries like India and China, with higher disposable income, are expected to further fuel the demand for the product. The management of pain in China is a critical issue for both patient types: cancer and non-cancer pain.
Pain Management Devices Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of pain management devices market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The major market players include Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., and Stryker Corp amongst others.
Pain Management Devices Market:
- By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps
- Ablation Devices
- By Application
- Neuropathic Pain
- Cancer Pain
- Facial & Migraine Pain
- Musculoskeletal Pain
- Others
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Pain Management Device Market
6. Market
Synopsis: Pain Management Device Market
7. Pain
Management Device Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Pain Management Device Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Pain Management Device Market
7.6. Porter’s
Five Force Analysis
8. Global Pain
Management Device Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Pain Management Device Market Revenue (US$ Mn)
8.2. Global
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1. Neuromodulation
and Neurostimulation Devices
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Analgesic
Infusion Pumps
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Ablation
Devices
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product
9. Global Pain
Management Device Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Neuropathic
Pain
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Cancer
Pain
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. Facial
and Migraine Pain
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2018
9.2.3.3. Market
Forecast, 2019 – 2027
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2018
9.2.3.5.1.2. Market
Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2018
9.2.3.5.2.2. Market
Forecast, 2019 – 2027
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2018
9.2.3.5.3.2. Market
Forecast, 2019 – 2027
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2018
9.2.3.5.4.2. Market
Forecast, 2019 – 2027
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2018
9.2.3.5.5.2. Market
Forecast, 2019 – 2027
9.2.4. Musculoskeletal
Pain
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2018
9.2.4.3. Market
Forecast, 2019 – 2027
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2018
9.2.4.5.1.2. Market
Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2018
9.2.4.5.2.2. Market
Forecast, 2019 – 2027
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2018
9.2.4.5.3.2. Market
Forecast, 2019 – 2027
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2018
9.2.4.5.4.2. Market
Forecast, 2019 – 2027
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2018
9.2.4.5.5.2. Market
Forecast, 2019 – 2027
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 – 2018
9.2.5.3. Market
Forecast, 2019 – 2027
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 – 2018
9.2.5.5.1.2. Market
Forecast, 2019 – 2027
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 – 2018
9.2.5.5.2.2. Market
Forecast, 2019 – 2027
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 – 2018
9.2.5.5.3.2. Market
Forecast, 2019 – 2027
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 – 2018
9.2.5.5.4.2. Market
Forecast, 2019 – 2027
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 – 2018
9.2.5.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. North
America Pain Management Device Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America Pain Management Device Market Revenue (US$ Mn)
10.2. North
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
10.2.1. Neuromodulation
and Neurostimulation Devices
10.2.2. Analgesic
Infusion Pumps
10.2.3. Ablation
Devices
10.3. North
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
10.3.1. Neuropathic
Pain
10.3.2. Cancer
Pain
10.3.3. Facial
and Migraine Pain
10.3.4. Musculoskeletal
Pain
10.3.5. Others
10.4. North
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Country
10.4.1. U.S
10.4.1.1. U.S
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
10.4.1.1.1. Neuromodulation
and Neurostimulation Devices
10.4.1.1.2. Analgesic
Infusion Pumps
10.4.1.1.3. Ablation
Devices
10.4.1.2. U.S
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
10.4.1.2.1. Neuropathic
Pain
10.4.1.2.2. Cancer
Pain
10.4.1.2.3. Facial
and Migraine Pain
10.4.1.2.4. Musculoskeletal
Pain
10.4.1.2.5. Others
10.4.2. Canada
10.4.2.1. Canada
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
10.4.2.1.1. Neuromodulation
and Neurostimulation Devices
10.4.2.1.2. Analgesic
Infusion Pumps
10.4.2.1.3. Ablation
Devices
10.4.2.2. Canada
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
10.4.2.2.1. Neuropathic
Pain
10.4.2.2.2. Cancer
Pain
10.4.2.2.3. Facial
and Migraine Pain
10.4.2.2.4. Musculoskeletal
Pain
10.4.2.2.5. Others
10.4.3. Mexico
10.4.3.1. Mexico
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
10.4.3.1.1. Neuromodulation
and Neurostimulation Devices
10.4.3.1.2. Analgesic
Infusion Pumps
10.4.3.1.3. Ablation
Devices
10.4.3.2. Mexico
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
10.4.3.2.1. Neuropathic
Pain
10.4.3.2.2. Cancer
Pain
10.4.3.2.3. Facial
and Migraine Pain
10.4.3.2.4. Musculoskeletal
Pain
10.4.3.2.5. Others
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Product
10.4.4.1.1. Neuromodulation
and Neurostimulation Devices
10.4.4.1.2. Analgesic
Infusion Pumps
10.4.4.1.3. Ablation
Devices
10.4.4.2. Rest
of North America Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Application
10.4.4.2.1. Neuropathic
Pain
10.4.4.2.2. Cancer
Pain
10.4.4.2.3. Facial
and Migraine Pain
10.4.4.2.4. Musculoskeletal
Pain
10.4.4.2.5. Others
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Product
10.5.3. By
Application
11. Europe
Pain Management Device Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
Pain Management Device Market Revenue (US$ Mn)
11.2. Europe
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.2.1. Neuromodulation
and Neurostimulation Devices
11.2.2. Analgesic
Infusion Pumps
11.2.3. Ablation
Devices
11.3. Europe
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1. Neuropathic
Pain
11.3.2. Cancer
Pain
11.3.3. Facial
and Migraine Pain
11.3.4. Musculoskeletal
Pain
11.3.5. Others
11.4. Europe
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1. France
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.1.1.1. Neuromodulation
and Neurostimulation Devices
11.4.1.1.2. Analgesic
Infusion Pumps
11.4.1.1.3. Ablation
Devices
11.4.1.2. France
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.4.1.2.1. Neuropathic
Pain
11.4.1.2.2. Cancer
Pain
11.4.1.2.3. Facial
and Migraine Pain
11.4.1.2.4. Musculoskeletal
Pain
11.4.1.2.5. Others
11.4.2. The UK
11.4.2.1. The
UK Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.2.1.1. Neuromodulation
and Neurostimulation Devices
11.4.2.1.2. Analgesic
Infusion Pumps
11.4.2.1.3. Ablation
Devices
11.4.2.2. The
UK Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.4.2.2.1. Neuropathic
Pain
11.4.2.2.2. Cancer
Pain
11.4.2.2.3. Facial
and Migraine Pain
11.4.2.2.4. Musculoskeletal
Pain
11.4.2.2.5. Others
11.4.3. Spain
11.4.3.1. Spain
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.3.1.1. Neuromodulation
and Neurostimulation Devices
11.4.3.1.2. Analgesic
Infusion Pumps
11.4.3.1.3. Ablation
Devices
11.4.3.2. Spain
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.4.3.2.1. Neuropathic
Pain
11.4.3.2.2. Cancer
Pain
11.4.3.2.3. Facial
and Migraine Pain
11.4.3.2.4. Musculoskeletal
Pain
11.4.3.2.5. Others
11.4.4. Germany
11.4.4.1. Germany
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.4.1.1. Neuromodulation
and Neurostimulation Devices
11.4.4.1.2. Analgesic
Infusion Pumps
11.4.4.1.3. Ablation
Devices
11.4.4.2. Germany
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.4.4.2.1. Neuropathic
Pain
11.4.4.2.2. Cancer
Pain
11.4.4.2.3. Facial
and Migraine Pain
11.4.4.2.4. Musculoskeletal
Pain
11.4.4.2.5. Others
11.4.5. Italy
11.4.5.1. Italy
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.5.1.1. Neuromodulation
and Neurostimulation Devices
11.4.5.1.2. Analgesic
Infusion Pumps
11.4.5.1.3. Ablation
Devices
11.4.5.2. Italy
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
11.4.5.2.1. Neuropathic
Pain
11.4.5.2.2. Cancer
Pain
11.4.5.2.3. Facial
and Migraine Pain
11.4.5.2.4. Musculoskeletal
Pain
11.4.5.2.5. Others
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
11.4.6.1.1. Neuromodulation
and Neurostimulation Devices
11.4.6.1.2. Analgesic
Infusion Pumps
11.4.6.1.3. Ablation
Devices
11.4.6.2. Nordic
Countries Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.6.2.1. Neuropathic
Pain
11.4.6.2.2. Cancer
Pain
11.4.6.2.3. Facial
and Migraine Pain
11.4.6.2.4. Musculoskeletal
Pain
11.4.6.2.5. Others
11.4.6.3. Nordic
Countries Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
11.4.7.1.1. Neuromodulation
and Neurostimulation Devices
11.4.7.1.2. Analgesic
Infusion Pumps
11.4.7.1.3. Ablation
Devices
11.4.7.2. Benelux
Union Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.7.2.1. Neuropathic
Pain
11.4.7.2.2. Cancer
Pain
11.4.7.2.3. Facial
and Migraine Pain
11.4.7.2.4. Musculoskeletal
Pain
11.4.7.2.5. Others
11.4.7.3. Benelux
Union Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
11.4.8.1.1. Neuromodulation
and Neurostimulation Devices
11.4.8.1.2. Analgesic
Infusion Pumps
11.4.8.1.3. Ablation
Devices
11.4.8.2. Rest
of Europe Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.8.2.1. Neuropathic
Pain
11.4.8.2.2. Cancer
Pain
11.4.8.2.3. Facial
and Migraine Pain
11.4.8.2.4. Musculoskeletal
Pain
11.4.8.2.5. Others
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Product
11.5.3. By
Application
12. Asia
Pacific Pain Management Device Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia
Pacific Pain Management Device Market Revenue (US$ Mn)
12.2. Asia
Pacific Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
12.2.1. Neuromodulation
and Neurostimulation Devices
12.2.2. Analgesic
Infusion Pumps
12.2.3. Ablation
Devices
12.3. Asia
Pacific Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
12.3.1. Neuropathic
Pain
12.3.2. Cancer
Pain
12.3.3. Facial
and Migraine Pain
12.3.4. Musculoskeletal
Pain
12.3.5. Others
12.4. Asia
Pacific Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Country
12.4.1. China
12.4.1.1. China
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.1.1.1. Neuromodulation
and Neurostimulation Devices
12.4.1.1.2. Analgesic
Infusion Pumps
12.4.1.1.3. Ablation
Devices
12.4.1.2. China
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1.2.1. Neuropathic
Pain
12.4.1.2.2. Cancer
Pain
12.4.1.2.3. Facial
and Migraine Pain
12.4.1.2.4. Musculoskeletal
Pain
12.4.1.2.5. Others
12.4.2. Japan
12.4.2.1. Japan
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.2.1.1. Neuromodulation
and Neurostimulation Devices
12.4.2.1.2. Analgesic
Infusion Pumps
12.4.2.1.3. Ablation
Devices
12.4.2.2. Japan
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
12.4.2.2.1. Neuropathic
Pain
12.4.2.2.2. Cancer
Pain
12.4.2.2.3. Facial
and Migraine Pain
12.4.2.2.4. Musculoskeletal
Pain
12.4.2.2.5. Others
12.4.3. India
12.4.3.1. India
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.3.1.1. Neuromodulation
and Neurostimulation Devices
12.4.3.1.2. Analgesic
Infusion Pumps
12.4.3.1.3. Ablation
Devices
12.4.3.2. India
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
12.4.3.2.1. Neuropathic
Pain
12.4.3.2.2. Cancer
Pain
12.4.3.2.3. Facial
and Migraine Pain
12.4.3.2.4. Musculoskeletal
Pain
12.4.3.2.5. Others
12.4.4. New
Zealand
12.4.4.1. New
Zealand Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
12.4.4.1.1. Neuromodulation
and Neurostimulation Devices
12.4.4.1.2. Analgesic
Infusion Pumps
12.4.4.1.3. Ablation
Devices
12.4.4.2. New
Zealand Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.4.2.1. Neuropathic
Pain
12.4.4.2.2. Cancer
Pain
12.4.4.2.3. Facial
and Migraine Pain
12.4.4.2.4. Musculoskeletal
Pain
12.4.4.2.5. Others
12.4.5. Australia
12.4.5.1. Australia
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.5.1.1. Neuromodulation
and Neurostimulation Devices
12.4.5.1.2. Analgesic
Infusion Pumps
12.4.5.1.3. Ablation
Devices
12.4.5.2. Australia
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
12.4.5.2.1. Neuropathic
Pain
12.4.5.2.2. Cancer
Pain
12.4.5.2.3. Facial
and Migraine Pain
12.4.5.2.4. Musculoskeletal
Pain
12.4.5.2.5. Others
12.4.6. South
Korea
12.4.6.1. South
Korea Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.6.1.1. Neuromodulation
and Neurostimulation Devices
12.4.6.1.2. Analgesic
Infusion Pumps
12.4.6.1.3. Ablation
Devices
12.4.6.2. South
Korea Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.6.2.1. Neuropathic
Pain
12.4.6.2.2. Cancer
Pain
12.4.6.2.3. Facial
and Migraine Pain
12.4.6.2.4. Musculoskeletal
Pain
12.4.6.2.5. Others
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
12.4.7.1.1. Neuromodulation
and Neurostimulation Devices
12.4.7.1.2. Analgesic
Infusion Pumps
12.4.7.1.3. Ablation
Devices
12.4.7.2. Southeast
Asia Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.7.2.1. Neuropathic
Pain
12.4.7.2.2. Cancer
Pain
12.4.7.2.3. Facial
and Migraine Pain
12.4.7.2.4. Musculoskeletal
Pain
12.4.7.2.5. Others
12.4.7.3. Southeast
Asia Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Product
12.4.8.1.1. Neuromodulation
and Neurostimulation Devices
12.4.8.1.2. Analgesic
Infusion Pumps
12.4.8.1.3. Ablation
Devices
12.4.8.2. Rest
of Asia Pacific Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.8.2.1. Neuropathic
Pain
12.4.8.2.2. Cancer
Pain
12.4.8.2.3. Facial
and Migraine Pain
12.4.8.2.4. Musculoskeletal
Pain
12.4.8.2.5. Others
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Product
12.5.3. By
Application
13. Middle
East and Africa Pain Management Device Market Analysis and Forecasts, 2019 -
2027
13.1. Overview
13.1.1. Middle
East and Africa Pain Management Device Market Revenue (US$ Mn)
13.2. Middle
East and Africa Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Product
13.2.1. Neuromodulation
and Neurostimulation Devices
13.2.2. Analgesic
Infusion Pumps
13.2.3. Ablation
Devices
13.3. Middle
East and Africa Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Application
13.3.1. Neuropathic
Pain
13.3.2. Cancer
Pain
13.3.3. Facial
and Migraine Pain
13.3.4. Musculoskeletal
Pain
13.3.5. Others
13.4. Middle
East and Africa Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
13.4.1.1.1. Neuromodulation
and Neurostimulation Devices
13.4.1.1.2. Analgesic
Infusion Pumps
13.4.1.1.3. Ablation
Devices
13.4.1.2. Saudi
Arabia Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1.2.1. Neuropathic
Pain
13.4.1.2.2. Cancer
Pain
13.4.1.2.3. Facial
and Migraine Pain
13.4.1.2.4. Musculoskeletal
Pain
13.4.1.2.5. Others
13.4.2. UAE
13.4.2.1. UAE
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
13.4.2.1.1. Neuromodulation
and Neurostimulation Devices
13.4.2.1.2. Analgesic
Infusion Pumps
13.4.2.1.3. Ablation
Devices
13.4.2.2. UAE
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
13.4.2.2.1. Neuropathic
Pain
13.4.2.2.2. Cancer
Pain
13.4.2.2.3. Facial
and Migraine Pain
13.4.2.2.4. Musculoskeletal
Pain
13.4.2.2.5. Others
13.4.3. Egypt
13.4.3.1. Egypt
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
13.4.3.1.1. Neuromodulation
and Neurostimulation Devices
13.4.3.1.2. Analgesic
Infusion Pumps
13.4.3.1.3. Ablation
Devices
13.4.3.2. Egypt
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
13.4.3.2.1. Neuropathic
Pain
13.4.3.2.2. Cancer
Pain
13.4.3.2.3. Facial
and Migraine Pain
13.4.3.2.4. Musculoskeletal
Pain
13.4.3.2.5. Others
13.4.4. Kuwait
13.4.4.1. Kuwait
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
13.4.4.1.1. Neuromodulation
and Neurostimulation Devices
13.4.4.1.2. Analgesic
Infusion Pumps
13.4.4.1.3. Ablation
Devices
13.4.4.2. Kuwait
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
13.4.4.2.1. Neuropathic
Pain
13.4.4.2.2. Cancer
Pain
13.4.4.2.3. Facial
and Migraine Pain
13.4.4.2.4. Musculoskeletal
Pain
13.4.4.2.5. Others
13.4.5. South
Africa
13.4.5.1. South
Africa Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
13.4.5.1.1. Neuromodulation
and Neurostimulation Devices
13.4.5.1.2. Analgesic
Infusion Pumps
13.4.5.1.3. Ablation
Devices
13.4.5.2. South
Africa Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
13.4.5.2.1. Neuropathic
Pain
13.4.5.2.2. Cancer
Pain
13.4.5.2.3. Facial
and Migraine Pain
13.4.5.2.4. Musculoskeletal
Pain
13.4.5.2.5. Others
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa Pain Management Device Market Revenue (US$ Mn) and
Forecasts, By Product
13.4.6.1.1. Neuromodulation
and Neurostimulation Devices
13.4.6.1.2. Analgesic
Infusion Pumps
13.4.6.1.3. Ablation
Devices
13.4.6.2. Rest
of Middle East & Africa Pain Management Device Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.6.2.1. Neuropathic
Pain
13.4.6.2.2. Cancer
Pain
13.4.6.2.3. Facial
and Migraine Pain
13.4.6.2.4. Musculoskeletal
Pain
13.4.6.2.5. Others
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Product
13.5.3. By
Application
14. Latin
America Pain Management Device Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America Pain Management Device Market Revenue (US$ Mn)
14.2. Latin
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Product
14.2.1. Neuromodulation
and Neurostimulation Devices
14.2.2. Analgesic
Infusion Pumps
14.2.3. Ablation
Devices
14.3. Latin
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Neuropathic
Pain
14.3.2. Cancer
Pain
14.3.3. Facial
and Migraine Pain
14.3.4. Musculoskeletal
Pain
14.3.5. Others
14.4. Latin
America Pain Management Device Market Revenue (US$ Mn) and Forecasts, By
Country
14.4.1. Brazil
14.4.1.1. Brazil
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
14.4.1.1.1. Neuromodulation
and Neurostimulation Devices
14.4.1.1.2. Analgesic
Infusion Pumps
14.4.1.1.3. Ablation
Devices
14.4.1.2. Brazil
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1.2.1. Neuropathic
Pain
14.4.1.2.2. Cancer
Pain
14.4.1.2.3. Facial
and Migraine Pain
14.4.1.2.4. Musculoskeletal
Pain
14.4.1.2.5. Others
14.4.2. Argentina
14.4.2.1. Argentina
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Product
14.4.2.1.1. Neuromodulation
and Neurostimulation Devices
14.4.2.1.2. Analgesic
Infusion Pumps
14.4.2.1.3. Ablation
Devices
14.4.2.2. Argentina
Pain Management Device Market Revenue (US$ Mn) and Forecasts, By Application
14.4.2.2.1. Neuropathic
Pain
14.4.2.2.2. Cancer
Pain
14.4.2.2.3. Facial
and Migraine Pain
14.4.2.2.4. Musculoskeletal
Pain
14.4.2.2.5. Others
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Product
14.4.3.1.1. Neuromodulation
and Neurostimulation Devices
14.4.3.1.2. Analgesic
Infusion Pumps
14.4.3.1.3. Ablation
Devices
14.4.3.2. Rest
of Latin America Pain Management Device Market Revenue (US$ Mn) and Forecasts,
By Application
14.4.3.2.1. Neuropathic
Pain
14.4.3.2.2. Cancer
Pain
14.4.3.2.3. Facial
and Migraine Pain
14.4.3.2.4. Musculoskeletal
Pain
14.4.3.2.5. Others
14.5. Key Segment
for Channeling Investments
14.5.1. By
Country
14.5.2. By
Product
14.5.3. By
Application
15. Competitive
Benchmarking
15.1. Market
Share Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player
Profiles
16.1. Abbott
Laboratories
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. B Braun
Melsungen AG
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT Analysis
16.2.7. Business
Strategies
16.3. Baxter
International Inc.
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Boston
Scientific Corp.
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. DJO
Global LLC.
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. Johnson
& Johnson
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7. Kimberly
Clark Corporation
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key
Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8. Medtronic
Plc.
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9. Pfizer,
Inc.
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key
Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10. Stryker
Corp.
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT
Analysis
16.10.7. Business Strategies
16.11. Other
Market Participants
17. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
